Boston-based Life Biosciences is testing whether reprogramming human cells can slow or even reverse the effects of aging. Unsplash Life Biosciences, a Boston-based biotechnology company founded in ...

Zhou’s study, "TBX20 improves contractility and mitochondrial function during direct human cardiac reprogramming," was recently published in Circulation. The most common cause of death worldwide is ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

The company described the round as fully subscribed and said the cash should keep operations running into the second half of ...

For the roughly 80 million people worldwide living with glaucoma, daily life often means watching the world slowly close in.